NDXH:PA:PA-Amundi Nasdaq-100 EUR Hedged Daily UCITS (EUR)

ETF | Others |

Last Closing

USD 487.3

Change

-12.80 (-2.56)%

Market Cap

USD 0.58B

Volume

2.66K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.40 (+0.86%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-10.50 (-1.83%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-7.62 (-1.85%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

-0.56 (-1.52%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.12 (-0.05%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-14.30 (-2.84%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

-5.44 (-1.50%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

-1.05 (-1.81%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

+0.13 (+1.68%)

USD 5.25B

ETFs Containing NDXH:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.50% 15% F 27% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.50% 15% F 27% F
Trailing 12 Months  
Capital Gain 15.16% 63% D 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.16% 62% D 70% C-
Trailing 5 Years  
Capital Gain 124.82% 96% N/A 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 124.82% 96% N/A 92% A
Average Annual (5 Year Horizon)  
Capital Gain 17.33% 85% B 81% B-
Dividend Return 17.33% 91% A- 89% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 25.40% 57% F 69% C-
Risk Adjusted Return 68.20% 70% C- 82% B
Market Capitalization 0.58B 67% D+ 71% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike